PatternsRadar
Sign in

JBCHEPHARMJBCHEPHARM

NSE
Full chart
2,408.90INR-97.10 (-3.87%)Close · 16 Jul 2026
11 May 2026Last results
—Sector
—Industry
₹38,687 CrMarket cap
54.5P/E (TTM)
66.8%Delivery

Filings & corporate actions

77 results filed
CSV
Next results · Q1 FY27
Due — expected by 13 Aug 2026
Estimate: filed 30–44 days after quarter end, last 5 times
Dividend
₹9.30 per share · last 29 May 2026
2026
  • 29 MaydividendDividend · ₹9.30 per share-1.7%
  • 11 MayresultsResults · Q4 FY26 · consolidated and standalone-3.3%NSE
  • 16 AprshareholdingShareholding · 31 Mar 2026-0.3%NSE
  • 11 FebdividendDividend · ₹12.70 per share-1.5%
  • 31 JanshareholdingShareholding · 23 Jan 2026+0.3%NSE
  • 16 JanresultsResults · Q3 FY26 · consolidated and standalone+1.2%NSE
  • 6 JanshareholdingShareholding · 31 Dec 2025+2.1%NSE

Reaction to results · all yearsrose on day 0 in 40 of 77 CSV

QuarterFiledDay 0+5D+20DRel vol
Q4 FY2611 May 2026-3.3%-1.7%-0.3%2.4×
Q3 FY2616 Jan 2026+1.2%-1.4%+3.9%1.6×
Q2 FY2611 Nov 2025-0.5%-4.2%-1.0%1.4×
Q1 FY2630 Jul 2025-0.7%-5.2%-3.2%0.6×
Q4 FY2514 May 2025+1.6%+4.5%+8.2%0.9×
Q3 FY255 Feb 2025-1.6%-6.7%-8.6%2.1×
Q2 FY256 Nov 2024-1.1%-10.6%-5.2%1.0×
Q1 FY258 Aug 2024-0.9%-0.2%-0.5%1.1×
Q4 FY2418 May 2024+1.0%-2.4%-1.3%0.3×
Q3 FY247 Feb 2024+4.3%-2.9%-9.1%19.7×
Q2 FY248 Nov 2023+0.7%+4.2%+3.1%1.5×
Q1 FY2410 Aug 20230.0%-1.6%+2.6%3.2×
Q4 FY2325 May 2023+7.0%+10.3%+24.6%10.4×
Q3 FY239 Feb 2023-3.7%-3.6%-3.8%1.4×
Q2 FY2311 Nov 2022-0.6%+4.8%+3.5%1.1×
Q1 FY235 Aug 2022+0.5%-2.5%+1.9%1.4×
Q4 FY2227 May 2022+3.5%+1.0%-0.5%1.7×
Q3 FY2215 Feb 2022-1.4%-1.3%-4.8%1.7×
Q2 FY2212 Nov 2021+0.1%-5.1%-4.9%0.6×
Q1 FY2213 Aug 2021-0.3%-4.8%-2.8%2.7×
Q4 FY2115 Jun 2021+1.3%+2.5%+20.4%1.5×
Q3 FY2111 Feb 2021+0.4%-7.2%+0.6%2.5×
Q2 FY2111 Nov 2020-0.6%-2.3%+6.5%1.1×
Q1 FY2115 Sept 2020+8.3%+20.6%+25.7%8.0×
Q4 FY2026 Jun 2020-2.2%+3.7%+5.3%1.7×
Q3 FY205 Feb 2020+4.9%+13.9%+15.3%3.0×
Q2 FY2013 Nov 2019-0.3%-2.1%+5.5%2.7×
Q1 FY2013 Aug 2019+0.3%+1.5%+5.4%1.7×
Q4 FY1922 May 2019+5.7%+8.0%+7.8%19.4×
Q3 FY1913 Feb 2019+1.1%+3.7%+7.8%0.8×
Q2 FY1921 Nov 2018-1.0%-0.7%-0.3%0.4×
Q1 FY1927 Aug 2018+1.1%+3.6%-9.0%2.5×
Q4 FY1811 Jul 2018+0.2%+3.2%+8.4%0.5×
Q3 FY1828 Feb 2018-1.3%-3.9%-2.1%1.4×
Q2 FY1815 Nov 2017+0.1%0.0%+3.0%0.1×
Q1 FY1821 Aug 2017+0.2%-2.0%+1.8%1.6×
Q4 FY179 Jun 2017+0.9%+1.5%-6.7%0.5×
Q3 FY1717 Feb 2017+0.3%-0.5%+1.4%0.2×
Q2 FY1719 Nov 2016-7.4%-1.6%-0.5%3.3×
Q1 FY1722 Sept 2016-0.5%-5.6%+4.8%0.1×
Q4 FY1623 May 2016-3.3%+0.7%-6.0%1.3×
Q3 FY164 Feb 2016+0.3%-11.2%-1.6%2.2×
Q2 FY165 Nov 2015+0.5%+1.3%-1.0%0.4×
Q1 FY167 Aug 2015+2.0%+5.3%+3.6%0.8×
Q4 FY1521 May 2015+2.5%0.0%-5.8%3.5×
Q3 FY155 Feb 2015+1.4%+4.1%+3.2%7.8×
Q2 FY1519 Nov 2014-1.6%+1.2%-5.3%0.7×
Q1 FY1511 Aug 2014+12.0%+13.7%+31.0%5.1×
Q4 FY1427 May 2014-6.7%-7.0%-4.4%1.3×
Q3 FY1412 Feb 2014+1.8%-2.0%+0.1%5.3×
Q2 FY145 Nov 2013-0.4%+8.2%+10.4%1.2×
Q1 FY1429 Jul 2013-3.5%-6.0%+5.0%0.7×
Q4 FY1327 May 2013-2.5%-3.7%-11.5%0.4×
Q3 FY136 Feb 2013+1.6%-5.5%-6.2%8.6×
Q2 FY132 Nov 2012+1.6%+15.4%+18.1%1.8×
Q1 FY136 Aug 2012-3.4%-7.5%-8.2%1.4×
Q4 FY1230 May 2012+1.6%+3.6%+4.4%0.6×
Q3 FY1225 Jan 2012-2.4%-7.2%-2.4%8.9×
Q2 FY1219 Oct 2011+1.4%-2.0%-13.0%4.0×
Q1 FY1229 Jul 2011+2.8%-4.3%-33.5%0.8×
Q4 FY1124 May 2011-0.1%-1.8%-0.6%7.1×
Q3 FY1113 Jan 2011-2.5%-8.2%-24.9%1.8×
Q2 FY1126 Oct 2010+4.8%+7.2%-0.4%5.3×
Q1 FY1129 Jul 2010-3.2%-4.9%+3.6%1.1×
Q4 FY106 May 2010-4.5%-10.8%-14.3%3.2×
Q3 FY1028 Jan 2010+1.8%+7.5%+5.2%0.6×
Q2 FY1026 Oct 2009-5.4%-7.3%-4.1%1.0×
Q1 FY1021 Jul 2009+0.9%+3.3%+8.5%2.0×
Q4 FY0912 May 2009-3.1%+5.7%+8.0%2.9×
Q3 FY0922 Jan 20090.0%-2.2%-7.7%3.7×
Q2 FY0920 Oct 2008+20.1%+13.6%+8.4%4.3×
Q1 FY0925 Jul 2008+13.8%+11.2%+12.5%8.4×
Q4 FY089 May 2008-3.1%-9.0%-18.8%0.4×
Q3 FY0829 Jan 2008-5.9%-9.7%-7.5%0.1×
Q2 FY0830 Oct 2007+6.6%+0.8%+0.3%3.1×
Q1 FY0828 Jul 2007-2.1%-5.6%+1.5%1.7×
Q4 FY0717 May 2007-3.5%-9.2%-9.2%3.9×
Average+0.5%-0.2%+0.5%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q4 FY26

CSV
Revenue YoY-4.8%
Profit YoY-30.4%
Interest cost YoY—
Revenue QoQ-15.1%
Profit QoQ-48.8%
CAGR2Y3Y4Y5Y6Y7Y
Revenue——————
Profit——————

Key data

CSV
Open2,506.00
Day range2,380.00 – 2,525.50
52-week range1,603.50 – 2,525.50
From 52w high-4.6%
RSI (14)61.0
ATR (14)59.79
Volume47.79L
Avg volume (20D)6.37L
Rel volume7.50×
Volatility (1Y)20.6%
Turnover₹1151.3Cr
SMA 50 / 2002,241.45 / 1,965.87

Delivery percentage

Latest · 16 Jul 202666.8%
20-day avg62.4%
1-year avg60.7%
Percentile (own history)73rd
Range12.8–95.0%
Sessions1,675

Over the last 20 sessions JBCHEPHARM settled 62.4% of its traded quantity, which is unusually high for an NSE equity. That is in line with its own one-year average of 60.7%. The latest session ranks higher than 73% of the 1,675 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Industry—
PeersSANSERAPNBBLUESTONECANBKAUBANKFORTIS

Performance returns

CSV
1D1W1M3M6M1Y
Price-3.87%-1.46%+9.85%+21.59%+26.05%+48.20%

Valuation

CSV
Market cap₹38,687 Cr
P/E (TTM)54.5
EPS (TTM)44.18
Shares outstanding16.06Cr
Listed—

Ownership

CSV
Promoter—
Promoter Δ QoQ—
Public—
FII—
DII—
Pledged—

Quarterly results · consolidated

CSV
Q1 FY26Q2 FY26Q3 FY26Q4 FY26
Revenue (₹ Cr)1,093.91,084.91,064.7904.2
YoY chg———-4.8%
Net profit (₹ Cr)202.4207.8197.9101.4
YoY chg———-30.4%
Net margin18.5%19.2%18.6%11.2%
EPS12.7513.0812.456.32

Shareholding over time

CSV

By quarter

31 Mar 2026 · promoter 48.80% · public 51.20%
30 Sept 2021: promoter 55.91%31 Dec 2021: promoter 54.00%31 Mar 2022: promoter 54.00%30 Jun 2022: promoter 54.00%30 Sept 2022: promoter 53.96%31 Dec 2022: promoter 53.95%31 Mar 2023: promoter 53.93%30 Jun 2023: promoter 53.91%30 Sept 2023: promoter 53.86%31 Dec 2023: promoter 53.83%31 Mar 2024: promoter 53.78%30 Jun 2024: promoter 53.77%30 Sept 2024: promoter 53.74%31 Dec 2024: promoter 53.66%31 Mar 2025: promoter 47.84%30 Jun 2025: promoter 47.73%30 Sept 2025: promoter 47.56%31 Dec 2025: promoter 47.55%23 Jan 2026: promoter 48.78%31 Mar 2026: promoter 48.80%
2021-092026-03
  • Promoter
  • Public and others
Promoter
48.80%
Public
51.20%
Promoter change
+0.02 pp
Filed
16 Apr 2026
FII
16.33%
DII
21.38%
Promoter pledged
0.00%

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.

Financials · quarterly statement

CSV
₹ crore, as filed
 Q1 FY24Q2 FY24Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26
Revenue from operations896.2881.7844.5861.71,004.41,000.6963.5949.51,093.91,084.91,064.7904.2
Other income5.67.77.416.65.910.08.014.514.615.318.312.0
Total income901.8889.4851.9878.41,010.31,010.6971.5964.01,108.51,100.21,083.0916.2
Total expenses707.5680.7667.9713.8770.5774.0753.5770.9836.9821.1816.1754.3
└ Finance costs12.110.412.59.45.62.12.61.51.11.41.91.2
└ Depreciation31.432.234.040.740.841.941.946.442.744.445.450.0
Profit before tax194.3208.7184.0164.6239.8236.5218.0193.0271.6279.2266.9134.7
Tax expense52.058.150.438.463.062.055.547.369.271.369.033.3
Net profit142.3150.6133.6126.2176.8174.6162.5145.7202.4207.8197.9101.4
EPS9.209.728.628.2211.3911.2410.469.3612.9913.2912.636.35
Net margin15.88%17.08%15.82%14.64%17.61%17.45%16.86%15.34%18.50%19.16%18.59%11.21%
PBT margin21.68%23.66%21.78%19.10%23.88%23.64%22.63%20.33%24.83%25.73%25.06%14.90%
Tax rate26.75%27.83%27.39%23.35%26.27%26.20%25.46%24.52%25.49%25.55%25.85%24.74%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 11 May 2026.

JBCHEPHARM at a glance

  • JBCHEPHARM closed at ₹2,408.9 on 16 Jul 2026, -3.87% on the day, +48.2% over one year, 4.6% below its 52-week high of ₹2,525.5.
  • Delivery was 66.8% of traded quantity on 16 Jul 2026, the 73rd percentile of its own 1,675 sessions with a reading (20-session average 62.4%, 1-year average 60.7%).
  • Market capitalisation is ₹38,687 crore at a trailing P/E of 54.5 (trailing EPS ₹44.18).
  • Q4 FY26 results (consolidated, filed 11 May 2026): revenue ₹904 crore (-4.8% year on year), net profit ₹101 crore (-30.4%); the price moved -3.3% on the first session after.
  • Promoters held 48.80% at 31 Mar 2026, up 0.02 percentage points on the previous filing.
  • Q1 FY27 results are expected between 30 Jul 2026 and 13 Aug 2026, going by past filing dates — an estimate, not an announcement.

About

CSV
Macro sector—
Basic industry—
ISININE572A01036
SeriesEQ
Listed—
History from2 Feb 1995
Sessions7,475

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 6 Oct 2026.

Other NSE equitys by turnover

CSV